BKM120 decreases cellular glycolytic metabolic activity in MB cell lines. by Ping Zhao (47228)

“…Data are presented as percent of vehicle control. *<i>p</i> < 0.05; **<i>p</i> < 0.01; ***<i>p</i> < 0.001.</p>…”

Parapapillary choroidal microvasculature in eyes with myopia and glaucoma (inner/outer whole annulus PPCMv densities=  0.092/0.069), glaucoma without myopia (0.092/0.071), and myop... by Yanin Suwan (4752099)

FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

“…<p>(A) Following 24 hours of treatment with FTY720, the viability of HuH6 cells measured using the alamarBlue cell viability assay was significantly decreased (LD₅₀ = 8.4 μM, p ≤ 0.05). …”

Cardiac adherent proliferating cells decrease cardiac mononuclear cell activation and cardiac damage in Coxsackievirus B3-infected mice. by Kapka Miteva (192634)

CaD prevents the decrease in tight junction protein levels and the increase in HUVECs permeability induced by VEGF₁₆₅. by Florence Njau (8298954)

Maps of median projected λ_<i>S</i> (a) and <i>R</i>₀ (b) across 1st-level sub-national administrative regions in selected African countries. by Keith Fraser (1868587)

Definitions of the features selected [50]. by Yu Zhang (12946)

Revisiting the sealed heating method–V158411 decreases Chk1 nuclear immunofluorescence in HT29 cells heated in a low well volume. by Andrew J. Massey (239469)

Test characteristics for identifying stenosis ≥ 50% in any limb from aorta till popliteal artery in the overall population (<i>n = 126 limbs</i>). by O. Stivalet (6890189)

Beta-catenin signaling is decreased in intermediate progenitor cells. by Christopher A. Mutch (243132)

“…Scale bars are 50 µm. * * = P<0.001, t test, two-tailed. (<b>C</b>) To further quantify signaling differences between Tbr2+ and Tbr2- cells, dorsolateral neocortices from E13.5 Eomes::GFP embryos (n = 3) were FACS sorted for GFP+ and GFP- cells (see cartoon). mRNA from these cells was isolated and reverse transcribed into cDNA for real-time PCR analysis. …”

Knockdown of MRN complex decreases HBV cccDNA level. by Kaitao Zhao (3617825)

Corticosterone treatment decreases MMP-2 promoter activity. by Eric A. Shikatani (131260)

“…MMP-2 mRNA levels were decreased with corticosterone treatment (A) (p = 0.006, n = 5). …”

Knockdown of MRN complex decreases HBV cccDNA level. by Kaitao Zhao (3617825)

Decreased NR1 and NR2A protein expression in 21-day group. by Chenxia Han (4020017)

“…The levels of both the NR1 <b>(A)</b> and NR2A <b>(B)</b> proteins of the 21-day group decreased compared with the control group, and the other two groups as well.…”

Substance P decreases PRL immunoreactivity in human epidermis. by Ewan A. Langan (405804)

“…PRL IR was measured using Image J software, showing that (C) epidermal PRL IR was significantly decreased by 100 nM Substance P treatment (p = 0.009). …”

Genes with decreased expression in TGFβ-induced EMT. by Kevin A. Maupin (190060)

<i>L. monocytogenes</i> causes LLO-mediated downregulation of CD117 but not FcεRI on BMMC and decreases chemotaxis. by Catherine E. Jobbings (382681)

Upregulation of autophagy decreases the age-related accumulation of hyperphosphorylated tau and ameliorates tau-induced locomotor defects in human Tau (0N3R) expressing transgenic flies. by Shreyasi Chatterjee (3531506)

HMNE3 decreased the activity of c-Src and the cellular stress response. by Yong-Chao Ma (174419)

Decrease of the input timing information with the change of the CV of PF amplitude from 0.05 to 0.5 and the number of PF inputs from 5 to 3. by Takuya Koumura (578507)

“…<p>Decrease of the input timing information with the change of the CV of PF amplitude from 0.05 to 0.5 and the number of PF inputs from 5 to 3.…”